FDA
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: approved
🇺🇸 Clorotrisin in United States
Clorotrisin (CHLOROTRIANISENE) regulatory status in United States.
Marketing authorisations
FDA
- Application: ANDA084652
- Marketing authorisation holder: BANNER PHARMACAPS
- Local brand name: CHLOROTRIANISENE
- Indication: CAPSULE — ORAL
- Status: approved
Clorotrisin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Clorotrisin approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Clorotrisin in United States?
SANOFI AVENTIS US holds the US marketing authorisation.